相似文献
1
Treatment of severe hypertension with methyldopa.
Br Med J. 1963 Jan 19;1(5324):151-5. doi: 10.1136/bmj.1.5324.151.
2
THE PLACE OF METHYLDOPA IN THE TREATMENT OF SEVERE HYPERTENSION.
JAMA. 1963 Oct 19;186:266-8. doi: 10.1001/jama.1963.63710030042021d.
3
Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):281-5. doi: 10.1016/j.ejogrb.2013.09.032. Epub 2013 Oct 1.
4
TREATMENT OF HYPERTENSION. THE SPECIAL PLACE OF ALPHA-METHYLDOPA. A SHORT TERM STUDY.
Calif Med. 1963 Sep;99(3):178-81.
5
[CLINICAL OBSERVATIONS ON THE TREATMENT OF ARTERIAL HYPERTENSION WITH ALPHA-METHYLDOPA].
Rass Int Clin Ter. 1964 May 15;44:471-82.
6
ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
Med Clin North Am. 1964 Mar;48:335-45. doi: 10.1016/s0025-7125(16)33467-8.
7
Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
BJOG. 2016 Jun;123(7):1135-41. doi: 10.1111/1471-0528.13568. Epub 2015 Aug 11.
8
9
METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
J Indian Med Assoc. 1964 May 1;42:405-10.
10
METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.
Br Med J. 1964 Jan 4;1(5374):27-30.
引用本文的文献
1
Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.
Br Med J. 1968 Jan 20;1(5585):135-44. doi: 10.1136/bmj.1.5585.135.
2
Hyperpyrexia During Treatment with Methyldopa.
Br Med J. 1963 Jul 6;2(5348):35-6. doi: 10.1136/bmj.2.5348.35.
3
To-day's Drugs.
Br Med J. 1963 Apr 13;1(5336):1003-6.
4
Methyldopa in Hypertension.
Br Med J. 1963 Feb 2;1(5326):282-3.
5
Methyldopa for primary hypertension.
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003893. doi: 10.1002/14651858.CD003893.pub3.
6
METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.
Br Med J. 1964 Mar 21;1(5385):736-9. doi: 10.1136/bmj.1.5385.736.
7
METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.
Br Med J. 1964 Jan 4;1(5374):27-30.
8
Methyldopa and depression.
Br Med J. 1963 Feb 23;1(5329):538-9. doi: 10.1136/bmj.1.5329.538-c.
9
Methyldopa in hypertension.
Br Med J. 1966 Jan 15;1(5480):119-20.
10
Some aspects of the long-term treatment of severe hypertension with methyldopa.
Postgrad Med J. 1968 Jan;44(507):66-9. doi: 10.1136/pgmj.44.507.66.
本文引用的文献
1
Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.
Science. 1960 Jun 24;131(3417):1890-1. doi: 10.1126/science.131.3417.1890.
2
Agranulocytosis caused by methyl dopa (Aldomet).
N Z Med J. 1961 Dec;60:567-70.
3
Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
Circulation. 1962 Feb;25:281-91. doi: 10.1161/01.cir.25.2.281.
4
Another hypotensive agent--methyldopa.
Br Med J. 1962 Jul 21;2(5298):156-8. doi: 10.1136/bmj.2.5298.156.
5
Methyldopa in the treatment of hypertension.
Lancet. 1962 Apr 14;1(7233):763-8. doi: 10.1016/s0140-6736(62)91782-8.
6
Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
N Engl J Med. 1960 Sep 22;263:585-8. doi: 10.1056/NEJM196009222631204.
7
Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine.
Ann N Y Acad Sci. 1960 Oct 11;88:1011-20. doi: 10.1111/j.1749-6632.1960.tb20092.x.
8
Hypertension: treated and untreated; a study of 400 cases.
Br Med J. 1959 May 30;1(5134):1361-8. doi: 10.1136/bmj.1.5134.1361.
9
[Inhibition of serotonin formation by alpha-methyl-DOPA].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194-205.
10
Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.
Arch Biochem Biophys. 1954 Aug;51(2):444-56. doi: 10.1016/0003-9861(54)90500-7.
Zotero 插件